Clinical Trials · NCT06169124
Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- National Cancer Institute (NCI)
- Enrollment
- 17
- Start date
- Feb 2024
- Locations
- 66 sites, United States
- Primary endpoint
- Objective response rate